CUSIP: 13739U104
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,573,942
-
Share change
-
-225,054
-
Total reported value
-
$10,511,056
-
Price per share
-
$6.68
-
Number of holders
-
29
-
Value change
-
-$1,914,719
-
Number of buys
-
15
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 13739U104:
Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q4 2014
As of 31 Dec 2014,
CANCER GENETICS INC - COM (CGIX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,573,942 shares.
The largest 10 holders included
BANK OF MONTREAL /CAN/, VANGUARD GROUP INC, Millrace Asset Group, Inc., GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, SSI INVESTMENT MANAGEMENT INC, Sterneck Capital Management, LLC, ROYCE & ASSOCIATES LLC, ARDSLEY ADVISORY PARTNERS, GEODE CAPITAL MANAGEMENT, LLC, and DIKER MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.